logo-loader
viewDigipath Inc

Cannabis cultivator Clinic Nevada selects DigiPath as lab tester

DigiPath's aims to improve reliability with state of the art lab equipment

Cannabis cultivator looks to DigiPath Labs to help them grow
Cannabis cultivator looks to DigiPath Labs to help them grow

DigiPath, Inc.’s (OTCMKTS:DIGP) subsidiary DigiPath Labs announced Thursday that The Clinic Nevada, LLC, selected the company to be their laboratory testing service provider.

The Clinic Nevada is a licensed cannabis cultivator, producer and dispenser in Las Vegas, Nevada and has retail and cultivation locations in Colorado and Illinois.

READ: Digipath Inc. plans to expand into California, other parts of the US this year

“In the few months we've been operational, DigiPath has gone above and beyond what we expected from a lab,” said Jon Marshall, COO of The Clinic Nevada.

“From quick turnarounds on test results to consulting services to their fantastic passionate team, we've been very pleased with everything DigiPath has to offer. We wanted to carry over our success from Colorado and we knew partnering with a quality lab like DigiPath would be the way to help us do that."

DigiPath Labs' developed its Las Vegas laboratory to improve the standard for cannabis testing, using state-of-the-art equipment and a higher standard of operating procedures to ensure reliable, predictable results. 

Quick facts: Digipath Inc

Price: 0.08095 USD

OTCMKTS:DIGP
Market: OTCQB
Market Cap: $4.02 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Zelira Therapeutics releases interim data for Phase II...

Zelira Therapeutics Ltd (ASX:ZLD) managing director Dr Richard Hopkins, chairman Osagie Imasogie and clinical trial principal investigator Professor Peter Eastwood, of the University of Western Australia, update Proactive on results from the company’s Phase II clinical trial of medicinal...

6 hours, 19 minutes ago

2 min read